SCHEMBL19112169

SCHEMBL19112169

CCC(CO)Nc1nc(N(C)c2cccc(C)c2)c2ncn(C(C)C)c2n1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.70
▸ CCNK O75909 4/20 0.61
▸ CDK12 Q9NYV4 4/20 0.61
▸ CDK2 P24941 14/20 0.56
▸ CCNE1 P24864 6/20 0.56
▸ CDK9 P50750 5/20 0.56
▸ CCNT1 O60563 3/20 0.56
▸ CCNE2 O96020 2/20 0.56
▸ CCNT2 O60583 1/20 0.56
▸ CDK5 Q00535 12/20 0.56
▸ CDK5R1 Q15078 10/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ NPC1 O15118 1/20 0.56
▸ POLB P06746 1/20 0.56
▸ MAPT P10636 1/20 0.56
▸ DYRK1A Q13627 9/20 0.55
▸ CCNA2 P20248 8/20 0.55
▸ CCNA1 P78396 8/20 0.55
▸ CDK1 P06493 7/20 0.55
▸ CCNB1 P14635 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19112172 1.00 NPSR1 (0.70) NPSR1CCNKCDK12CDK2CCNE1
SCHEMBL22651834 0.90 NPSR1 (0.85) NPSR1CCNKCDK12CDK2CCNE1
SCHEMBL15387124 0.90 NPSR1 (0.67) NPSR1CCNKCDK12CDK2CCNE1
SCHEMBL30356263 0.90 NPSR1 (0.67) NPSR1CCNKCDK12CDK2CCNE1
SCHEMBL19112192 0.90 NPSR1 (0.67) NPSR1CCNKCDK12CDK2CCNE1
SCHEMBL19112178 0.90 NPSR1 (0.67) NPSR1CCNKCDK12CDK2CCNE1
Hydrochloric Acid SCHEMBL23927317 0.89 NPSR1 (0.66) NPSR1CCNKCDK12CDK2CCNE1
Hydrochloric Acid SCHEMBL23927315 0.89 NPSR1 (0.66) NPSR1CCNKCDK12CDK2CCNE1
Hydrochloric Acid SCHEMBL30268945 0.89 NPSR1 (0.66) NPSR1CCNKCDK12CDK2CCNE1
SCHEMBL23993161 0.85 CDK1 (0.65) NPSR1CCNKCDK12CDK2CCNE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901154-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2021-10-27 — — EP disclosed
EP-2664619-B1 Purine derivatives as tools for screening anti-Alzheimer compounds MANROS THERAPEUTICS (FR) 2017-07-12 — — EP disclosed
Send feedback